Exactech Company Profile (NASDAQ:EXAC)

About Exactech (NASDAQ:EXAC)

Exactech, Inc. develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company's segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines. The Company distributes joint replacement systems, including knee, hip, spine and extremity implant systems, and biologic products and services and bone cement materials used in orthopedic surgery and dental procedures. The Exactech Knee System provides solutions for partial, primary and revision total knee arthroplasty. Its hip solutions address the continuum of hip arthroplasty. It manufactures and distributes various products and services designed for the healing and regeneration of bone and soft tissue, including products, which contain human allograft.

Industry, Sector and Symbol:

Sector: Medical
Industry: Medical Equipment, Supplies & Distribution - NEC
Sub-Industry: Health Care Equipment
Symbol: NASDAQ:EXAC
CUSIP: 30064E10
Web: www.exac.com

Capitalization:

Market Cap: $434.38 million
Outstanding Shares: 14,312,000

Average Prices:

50 Day Moving Avg: $30.33
200 Day Moving Avg: $27.77
52 Week Range: $22.20 - $31.90

P/E:

Trailing P/E Ratio: 1270.83
Foreward P/E Ratio: 21.18
P/E Growth: 2.29

Sales & Book Value:

Annual Revenue: $261.76 million
Price / Sales: 1.67
Book Value: $16.79 per share
Price / Book: 1.82

Profitability:

EBIDTA: $42.88 million
Net Margins: 0.13%
Return on Equity: 7.27%
Return on Assets: 5.86%

Debt:

Debt-to-Equity Ratio: 0.07%
Current Ratio: 3.97%
Quick Ratio: 2.10%

Misc:

Average Volume: 29,216 shs.
Beta: 1.03
Short Ratio: 3.69

Frequently Asked Questions for Exactech (NASDAQ:EXAC)

What is Exactech's stock symbol?

Exactech trades on the NASDAQ under the ticker symbol "EXAC."

How were Exactech's earnings last quarter?

Exactech, Inc. (NASDAQ:EXAC) issued its quarterly earnings results on Tuesday, April, 25th. The company reported $0.34 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.31 by $0.03. The company earned $69.48 million during the quarter, compared to the consensus estimate of $67.05 million. Exactech had a net margin of 0.13% and a return on equity of 7.27%. Exactech's revenue was up 6.4% on a year-over-year basis. During the same period in the prior year, the company earned $0.31 EPS. View Exactech's Earnings History.

When will Exactech make its next earnings announcement?

Exactech is scheduled to release their next quarterly earnings announcement on Monday, July, 31st 2017. View Earnings Estimates for Exactech.

What guidance has Exactech issued on next quarter's earnings?

Exactech issued an update on its FY17 earnings guidance on Tuesday, April, 25th. The company provided earnings per share (EPS) guidance of $1.26 - $1.32 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.29. The company issued revenue guidance of $266 million - $272 million, compared to the consensus revenue estimate of $267.87 million.Exactech also updated its Q2 guidance to $0.32 - $0.34 EPS.

Who are some of Exactech's key competitors?

Some companies that are related to Exactech include Orthofix International N.V. (OFIX), AtriCure (ATRC), Intersect ENT (XENT), CryoLife (CRY), Meridian Bioscience (VIVO), Consort Medical plc (CSRT), Landauer (LDR), Antares Pharma (ATRS), Invacare Corporation (IVC), STAAR Surgical Company (STAA), Syneron Medical (ELOS), Sientra (SIEN), Ocular Therapeutix (OCUL), Transenterix (TRXC), Transenterix (TRXC), T2 Biosystems (TTOO), Bioquell plc (BQE) and Cytori Therapeutics (CYTX).

Who are Exactech's key executives?

Exactech's management team includes the folowing people:

R. William Petty M.D., Executive Chairman of the Board
David W. Petty, Chief Executive Officer, President and Director
Joel C. Phillips CPA, Chief Financial Officer, Executive Vice President, Treasurer
Bruce E. Thompson, Senior Vice President , General manager- Biologics and Spine Division
Gary J. Miller Ph.D., Executive Vice President - Research and Development
Donna M. Edwards, Vice President, Legal and General Counsel
Betty A. Petty, Vice President - Administration, Corporate Secretary
James G. Binch, Independent Director
W. Andrew Krusen Jr., Independent Director
William B. Locander Ph.D., Independent Director

Who owns Exactech stock?

Exactech's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Thomson Horstmann & Bryant Inc. (1.91%), Clean Yield Group (0.34%), Kirr Marbach & Co. LLC IN (0.12%) and Bank of Montreal Can (0.03%). Company insiders that own Exactech stock include Betty A Petty, Bruce E Thompson, David W Petty, Donna M Edwards, Fern Watts, Gary J Miller, James G Binch, Joel C Phillips and William B Locander. View Institutional Ownership Trends for Exactech.

Who sold Exactech stock? Who is selling Exactech stock?

Exactech's stock was sold by a variety of institutional investors in the last quarter, including Clean Yield Group. Company insiders that have sold Exactech stock in the last year include Bruce E Thompson, David W Petty, Fern Watts, James G Binch, Joel C Phillips and William B Locander. View Insider Buying and Selling for Exactech.

Who bought Exactech stock? Who is buying Exactech stock?

Exactech's stock was purchased by a variety of institutional investors in the last quarter, including Thomson Horstmann & Bryant Inc., Kirr Marbach & Co. LLC IN and Bank of Montreal Can. View Insider Buying and Selling for Exactech.

How do I buy Exactech stock?

Shares of Exactech can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Exactech's stock price today?

One share of Exactech stock can currently be purchased for approximately $30.50.

MarketBeat Community Rating for Exactech (NASDAQ EXAC)

Community Ranking:		2.0 out of 5 ( )
Outperform Votes:		59 (Vote Outperform)
Underperform Votes:		85 (Vote Underperform)
Total Votes:		144

MarketBeat's community ratings are surveys of what our community members think about Exactech and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Consensus Ratings for Exactech (NASDAQ:EXAC) (How are Consensus Ratings Calculated?)

Ratings Breakdown:	No ratings tracked in the last 12 months.
Consensus Rating:	N/A (Score: NaN)
Consensus Price Target:	N/A

Analysts' Ratings History for Exactech (NASDAQ:EXAC)

Show:

Date	Firm	Action	Rating	Price Target	Impact on Share Price
4/13/2016	Robert W. Baird	Upgrade	Neutral -> Outperform	$21.00 -> $26.00	N/A
10/28/2015	Northland Securities	Lower Price Target	Market Perform	$22.00 -> $20.00	N/A
7/29/2015	Canaccord Genuity	Reiterated Rating	Hold	$22.00	N/A

(Data available from 7/22/2015 forward)

Earnings History for Exactech (NASDAQ:EXAC)

Earnings by Quarter for Exactech (NASDAQ:EXAC)

Earnings History by Quarter for Exactech (NASDAQ EXAC)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
7/31/2017
4/25/2017	Q1 2017	$0.31	$0.34	$67.05 million	$69.48 million	View	N/A
2/21/2017	Q416	$0.32	$0.34	$66.00 million	$66.20 million	View	Listen
10/31/2016	Q316	$0.22	$0.22	$58.69 million	$59.90 million	View	N/A
8/1/2016	Q216	$0.30	$0.31	$64.18 million	$66.10 million	View	N/A
4/26/2016	Q116	$0.29	$0.31	$63.63 million	$65.30 million	View	N/A
2/16/2016	Q415	$0.28	$0.29	$61.29 million	$62.70 million	View	Listen
10/27/2015	Q315	$0.23	$0.20	$58.46 million	$56.20 million	View	Listen
7/28/2015	Q215	$0.27	$0.26	$62.13 million	$61.50 million	View	Listen
4/28/2015	Q115	$0.30	$0.29	$63.71 million	$61.40 million	View	N/A
2/17/2015	Q414	$0.33	$0.36	$63.30 million	$63.30 million	View	N/A
10/21/2014	Q314	$0.25	$0.21	$58.60 million	$57.90 million	View	N/A
7/28/2014	Q214	$0.30	$0.30	$63.80 million	$63.92 million	View	N/A
4/21/2014	Q114	$0.29	$0.30	$63.05 million	$63.30 million	View	N/A
2/19/2014	Q413	$0.31	$0.33	$63.20 million	$61.60 million	View	N/A
10/22/2013	Q313	$0.21	$0.23	$55.36 million	$55.70 million	View	N/A
7/23/2013	Q2 2013	$0.25	$0.27	$58.42 million	$60.60 million	View	N/A
2/26/2013	Q4 2012	$0.28	$0.29	$58.20 million	$59.30 million	View	N/A
10/30/2012	Q312	$0.17	$0.19	$50.20 million	$51.30 million	View	N/A
7/31/2012		$0.23	$0.23			View	N/A
5/1/2012		$0.23	$0.25			View	N/A
2/28/2012		$0.25	$0.18			View	N/A
11/1/2011		$0.20	$0.15			View	N/A
8/2/2011		$0.26	$0.28			View	N/A
5/3/2011		$0.27	$0.28			View	N/A
2/28/2011		$0.23	$0.23			View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Exactech (NASDAQ:EXAC)

Current Year EPS Consensus Estimate: $1.29 EPS
Next Year EPS Consensus Estimate: $1.44 EPS

Dividend History for Exactech (NASDAQ:EXAC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading and Institutional Ownership History for Exactech (NASDAQ:EXAC)

Insider Ownership Percentage: 28.30%
Institutional Ownership Percentage: 63.97%

Institutional Ownership by Quarter for Exactech (NASDAQ:EXAC)

Insider Trades by Quarter for Exactech (NASDAQ:EXAC)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
5/31/2017	William B Locander	Director	Sell	988	$30.34	$29,975.92
5/23/2017	Joel C Phillips	CFO	Sell	7,610	$30.71	$233,703.10
3/9/2017	Fern Watts	Director	Sell	1,000	$24.25	$24,250.00
3/8/2017	James G Binch	Director	Sell	3,588	$24.16	$86,686.08
2/24/2017	Bruce E Thompson	SVP	Sell	4,906	$24.77	$121,521.62
11/3/2016	James G Binch	Director	Sell	600	$22.61	$13,566.00
8/25/2016	Fern Watts	Director	Sell	1,100	$27.68	$30,448.00
8/22/2016	Bruce E Thompson	SVP	Sell	1,433	$27.97	$40,081.01
8/19/2016	David W Petty	CEO	Sell	3,550	$27.75	$98,512.50
7/1/2016	Joel C Phillips	CFO	Sell	3,000	$26.75	$80,250.00
6/8/2016	Gary J Miller	EVP	Sell	9,800	$25.16	$246,568.00
6/7/2016	Bruce E Thompson	SVP	Sell	2,000	$25.07	$50,140.00
6/3/2016	James G Binch	Director	Sell	600	$24.86	$14,916.00
6/2/2016	Gary J Miller	EVP	Sell	3,381	$25.11	$84,896.91
5/25/2016	Gary J Miller	EVP	Sell	9,319	$25.10	$233,906.90
5/18/2016	Gary J Miller	EVP	Sell	9,664	$24.37	$235,511.68
5/9/2016	Joel C Phillips	CFO	Sell	3,900	$23.13	$90,207.00
5/5/2016	James G Binch	Director	Sell	1,870	$23.00	$43,010.00
5/3/2016	Fern Watts	Director	Sell	2,000	$22.76	$45,520.00
4/29/2016	Betty A Petty	VP	Sell	18,000	$22.65	$407,700.00
4/27/2016	Gary J Miller	EVP	Sell	9,851	$24.06	$237,015.06
4/26/2016	Gary J Miller	EVP	Sell	7,985	$23.11	$184,533.35
4/25/2016	Gary J Miller	EVP	Sell	4,725	$23.14	$109,336.50
3/31/2016	Gary J Miller	EVP	Sell	7,000	$19.95	$139,650.00
3/10/2016	Joel C Phillips	CFO	Sell	2,000	$18.58	$37,160.00
3/8/2016	Betty A Petty	VP	Sell	15,964	$19.06	$304,273.84
3/7/2016	Donna M Edwards	VP	Sell	10,000	$18.85	$188,500.00
3/3/2016	Gary J Miller	EVP	Sell	7,017	$19.23	$134,936.91
3/3/2016	William B Locander	Director	Sell	2,435	$19.25	$46,873.75
12/10/2015	James G Binch	Director	Sell	1,500	$17.03	$25,545.00
12/9/2015	Fern Watts	Director	Sell	1,200	$17.32	$20,784.00
12/1/2015	Bruce E. Thompson	SVP	Sell	21,904	$17.57	$384,853.28
11/24/2015	Bruce E. Thompson	SVP	Sell	900	$17.75	$15,975.00
9/1/2015	Bruce E. Thompson	SVP	Sell	2,107	$19.45	$40,981.15
5/28/2015	Joel C Phillips	CFO	Sell	5,000	$21.76	$108,800.00
5/20/2015	William B Locander	Director	Sell	3,350	$21.50	$72,025.00
5/18/2015	Fern Watts	Director	Sell	2,200	$21.21	$46,662.00
5/4/2015	Joel C Phillips	CFO	Sell	2,700	$21.67	$58,509.00
3/20/2015	Gary J Miller	EVP	Sell	32,800	$24.95	$818,360.00
2/24/2015	R William Petty	Chairman	Sell	45,067	$23.08	$1,040,146.36
2/2/2015	Betty A Petty	VP	Sell	7,500	$20.74	$155,550.00
1/8/2015	Gary J Miller	EVP	Sell	4,145	$23.17	$96,039.65
12/3/2014	Gary J Miller	EVP	Sell	5,000	$21.83	$109,150.00
11/25/2014	Betty A Petty	Major Shareholder	Sell	12,500	$21.86	$273,250.00
11/25/2014	Bruce E Thompson	SVP	Sell	6,500	$22.05	$143,325.00
10/31/2014	Joel C Phillips	CFO	Sell	5,000	$21.44	$107,200.00
9/5/2014	R William Petty	Major Shareholder	Sell	25,000	$23.68	$592,000.00
8/25/2014	Albert H Burstein	Director	Sell	8,852	$23.73	$210,057.96
7/1/2014	Gary J Miller	EVP	Sell	12,392	$26.21	$324,794.32
6/26/2014	Gary J Miller	EVP	Sell	1,894	$25.06	$47,463.64
6/25/2014	Gary J Miller	EVP	Sell	16,356	$25.33	$414,297.48
6/10/2014	Joel C Phillips	CFO	Sell	5,000	$24.77	$123,850.00
6/5/2014	Bruce E Thompson	SVP	Sell	1,667	$23.50	$39,174.50
6/5/2014	Joel C Phillips	CFO	Sell	5,000	$23.21	$116,050.00
5/29/2014	Bruce E Thompson	SVP	Sell	1,588	$23.00	$36,524.00
5/12/2014	David Petty	CEO	Sell	10,287	$20.99	$215,924.13
5/8/2014	David Petty	CEO	Sell	7,976	$21.51	$171,563.76
4/24/2014	Bruce Thompson	SVP	Sell	2,412	$23.78	$57,357.36
4/23/2014	William Locander	Director	Sell	4,500	$23.18	$104,310.00
2/28/2014	William Locander	Director	Sell	1,819	$23.16	$42,128.04
12/5/2013	R William Petty	CEO	Sell	10,000	$23.67	$236,700.00
11/12/2013	Bruce Thompson	SVP	Sell	3,079	$23.35	$71,894.65
8/22/2013	William Locander	Director	Sell	1,521	$19.05	$28,975.05
7/15/2013	Gary J Miller	EVP	Sell	10,250	$20.07	$205,717.50
7/8/2013	Gary J Miller	EVP	Sell	1,000	$20.00	$20,000.00
6/17/2013	Gary J Miller	EVP	Sell	8,125	$18.98	$154,212.50
6/5/2013	R William Petty	CEO	Sell	3,885	$18.00	$69,930.00
6/4/2013	R William Petty	CEO	Sell	14,257	$18.01	$256,768.57
5/28/2013	R William Petty	CEO	Sell	20,000	$18.21	$364,200.00
5/22/2013	R William Petty	CEO	Sell	11,493	$18.13	$208,368.09
5/17/2013	R William Petty	CEO	Sell	17,472	$18.05	$315,369.60
5/16/2013	R William Petty	CEO	Sell	22,893	$18.22	$417,110.46
5/9/2013	R William Petty	CEO	Sell	10,000	$18.25	$182,500.00
5/8/2013	David W Petty	President	Sell	8,000	$18.35	$146,800.00
12/4/2012	R William Petty	CEO	Sell	14,048	$16.29	$228,841.92

(Data available from 1/1/2013 forward)

Headline Trends for Exactech (NASDAQ:EXAC) Latest Headlines for Exactech (NASDAQ:EXAC)

Source:

Date	Headline
	Exactech, Inc. breached its 50 day moving average in a Bullish Manner : EXAC-US : July 18, 2017 finance.yahoo.com - July 18 at 7:57 PM
	Exactech, Inc. (EXAC) Receives Consensus Rating of "Strong Buy" from Brokerages www.americanbankingnews.com - July 18 at 11:34 AM
	Exactech Schedules Second Quarter 2017 Earnings Release and Conference Call finance.yahoo.com - July 13 at 7:49 PM
	Exactech Introduces New Computer-Assisted Software Application for Simplified Guidance in Total Knee Replacement finance.yahoo.com - June 29 at 4:49 PM
	Exactech, Inc. breached its 50 day moving average in a Bearish Manner : EXAC-US : June 28, 2017 finance.yahoo.com - June 28 at 6:10 PM
	Exactech Expands Presence in Japan with Newly Approved Shoulder, Knee and Hip Replacement Systems finance.yahoo.com - June 22 at 9:53 AM
	ETFs with exposure to Exactech, Inc. : June 19, 2017 finance.yahoo.com - June 19 at 6:22 PM
	Exactech, Inc. :EXAC-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017 finance.yahoo.com - June 16 at 3:53 PM
	Alteon® HA Femoral Hip Stem Rounds Out Big Week of First Surgeries for Exactech finance.yahoo.com - June 12 at 5:57 PM
	Exactech Announces Successful First Surgeries with New Equinoxe® Preserve Stem and ExactechGPS® Shoulder Application finance.yahoo.com - June 6 at 5:29 PM
	Exactech, Inc. (EXAC) Director Sells $29,975.92 in Stock www.americanbankingnews.com - June 1 at 8:32 PM
	Exactech Announces Successful First Surgeries with Truliant® Knee System finance.yahoo.com - May 31 at 9:29 AM
	Exactech, Inc. (EXAC) Short Interest Update www.americanbankingnews.com - May 26 at 9:45 AM
	Joel C. Phillips Sells 7,610 Shares of Exactech, Inc. (EXAC) Stock www.americanbankingnews.com - May 25 at 8:06 PM
	Exactech (EXAC) Gets FDA Approval for ExactechGPS Application finance.yahoo.com - May 19 at 5:40 AM
	Exactech (EXAC) Gains FDA 510(k) Clearance for ExactechGPS Shoulder Application www.streetinsider.com - May 16 at 10:02 PM
	Exactech Receives 510(k) Clearance for Computer-Assisted Shoulder Arthroplasty Technology finance.yahoo.com - May 15 at 11:35 AM
	Exactech (EXAC) Getting Favorable Press Coverage, Study Shows www.americanbankingnews.com - May 3 at 12:14 AM
	Ventricular Assist Device (VAD) Market Forecast 2017-2027 www.marketwatch.com - May 2 at 7:32 PM
	Exactech, Inc. (EXAC) Lifted to Hold at Zacks Investment Research www.americanbankingnews.com - May 1 at 9:28 PM
	FY2018 EPS Estimates for Exactech, Inc. (EXAC) Lifted by Analyst www.americanbankingnews.com - May 1 at 2:00 PM
	FY2021 Earnings Forecast for Exactech, Inc. Issued By Gabelli (EXAC) www.americanbankingnews.com - April 29 at 12:48 AM
	BRIEF-Exactech reports Q1 earnings per share $0.32 www.reuters.com - April 27 at 10:43 PM
	Exactech, Inc. (EXAC) Upgraded to "B" at TheStreet www.americanbankingnews.com - April 27 at 4:57 PM
	Edited Transcript of EXAC earnings conference call or presentation 26-Apr-17 2:00pm GMT finance.yahoo.com - April 27 at 11:19 AM
	Exactech (EXAC) Getting Somewhat Favorable News Coverage, Report Shows www.americanbankingnews.com - April 27 at 12:10 AM
	Exactech, Inc. (EXAC) Lifted to "Hold" at Zacks Investment Research www.americanbankingnews.com - April 25 at 8:50 PM
	Exactech, Inc. (EXAC) Updates Q2 Earnings Guidance www.americanbankingnews.com - April 25 at 7:02 PM
	Exactech, Inc. (EXAC) Issues FY17 Earnings Guidance www.americanbankingnews.com - April 25 at 7:02 PM
	Exactech, Inc. (EXAC) Announces Quarterly Earnings Results www.americanbankingnews.com - April 25 at 6:22 PM
	Exactech posts 1Q profit marketbeat.com - April 25 at 4:47 PM
	Exactech Q1 Revenue Up 6% to $69.5 Million on 21% Extremities Growth finance.yahoo.com - April 25 at 4:46 PM
	Exactech (EXAC) Receives Daily News Sentiment Rating of 0.17 www.americanbankingnews.com - April 23 at 6:34 PM
	Exactech (EXAC) Receiving Very Positive News Coverage, Study Finds www.americanbankingnews.com - April 19 at 10:30 AM
	Exactech, Inc. (EXAC) Given Consensus Recommendation of "Strong Buy" by Brokerages www.americanbankingnews.com - April 17 at 10:10 PM
	Exactech (EXAC) Getting Somewhat Positive Media Coverage, Report Shows www.americanbankingnews.com - April 15 at 4:03 PM
	Exactech, Inc. breached its 50 day moving average in a Bearish Manner : EXAC-US : April 14, 2017 finance.yahoo.com - April 14 at 10:11 AM
	Exactech Schedules First Quarter 2017 Earnings Release and Conference Call finance.yahoo.com - April 12 at 5:08 PM
	Exactech, Inc. (EXAC) Downgraded by Zacks Investment Research www.americanbankingnews.com - April 10 at 11:33 PM
	Exactech New Scientific and Clinical Research Presented at 2017 Orthopaedic Research Society Annual Meeting finance.yahoo.com - March 30 at 5:33 PM
	Global Market Study on Hip Replacement: North America to Register a CAGR of 4.3% Between 2016 and 2024 www.prnewswire.com - March 16 at 11:28 PM
	Exactech Announces Full Launch of Three Revision Systems and Expansion of Advanced Surgical Technologies at AAOS 2017 Annual Meeting, Exhibit #1433 finance.yahoo.com - March 14 at 12:44 PM
	Exactech Announces Investor Presentation at 12th Annual CanaccordGenuity Musculoskeletal Conference finance.yahoo.com - March 13 at 11:51 AM
	EXACTECH INC Financials finance.yahoo.com - March 11 at 5:04 PM
	EXACTECH INC Files SEC form 10-K, Annual Report biz.yahoo.com - March 8 at 5:56 PM
	Knee Implant Market - U.S. Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024 www.bizjournals.com - March 7 at 4:55 PM
	Exactech's (EXAC) CEO David Petty on Q4 2016 Results - Earnings Call Transcript seekingalpha.com - February 22 at 5:22 PM
	Exactech Posts Q4 Loss of 82 Cents a Share (EXAC) www.investopedia.com - February 22 at 5:22 PM
	Exactech Posts Q4 Loss of 82 Cents a Share www.investopedia.com - February 22 at 5:22 PM
	Q4 2016 Exactech Inc Earnings Release - Before Market Open us.rd.yahoo.com - February 22 at 8:55 AM